Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2013 4
2014 5
2015 4
2016 9
2017 2
2020 2
2021 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Pfister C, Gravis G, Flechon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulie M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Lancet Oncol. 2024 Feb;25(2):255-264. doi: 10.1016/S1470-2045(23)00587-9. Epub 2023 Dec 21. Lancet Oncol. 2024. PMID: 38142702 Clinical Trial.
Prostate cancer in deceased organ donors: a review.
Doerfler A, Tillou X, Le Gal S, Desmonts A, Orczyk C, Bensadoun H. Doerfler A, et al. Transplant Rev (Orlando). 2014 Jan;28(1):1-5. doi: 10.1016/j.trre.2013.10.003. Epub 2013 Oct 24. Transplant Rev (Orlando). 2014. PMID: 24321301 Review.
Flexible and rigid ureteroscopy in outpatient surgery.
Oitchayomi A, Doerfler A, Le Gal S, Chawhan C, Tillou X. Oitchayomi A, et al. Among authors: doerfler a. BMC Urol. 2016 Jan 28;16:6. doi: 10.1186/s12894-016-0124-z. BMC Urol. 2016. PMID: 26822017 Free PMC article.
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes.
Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M, Patard JJ, Méjean A, Bensalah K; members of the Kidney Cancer group of the CCAFU. Bigot P, et al. Among authors: doerfler a. Urol Oncol. 2017 Jan;35(1):35.e15-35.e19. doi: 10.1016/j.urolonc.2016.08.012. Epub 2016 Sep 28. Urol Oncol. 2017. PMID: 27692834 Free PMC article.
25 results